Drug Profile
KHK 4577
Alternative Names: KHK4577Latest Information Update: 16 Jul 2019
Price :
$50
*
At a glance
- Originator Kyowa Hakko Kirin
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 24 Jul 2015 Discontinued - Phase-II for Atopic dermatitis in Japan (PO)
- 30 Nov 2013 Phase-II clinical trials in Atopic dermatitis in Japan (PO)
- 24 Jan 2013 Phase-I clinical trials in Inflammation in Japan (PO)